Activation of the TGF-β/Smad signaling pathway in focal segmental glomerulosclerosis

Kidney International

Volumn 64, Issue 5, 2003, Pages 1715-1721

  Kim, J Hoon ^a   Kim, Byoung Kwon ^a   Moon, Kyung Chul ^a   Hong, Hye Kyoung ^a   Lee, Hyun Soon ^a  

^a Seoul National University   (South Korea)

Author keywords

Extracellular matrix; Glomerular epithelial cells; Glomerulosclerosis; Phosphorylated Smads; TGF type II receptor; Thrombospondin 1

Indexed keywords

EPITOPE; ISOPROTEIN; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; WT1 PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; EPITHELIUM CELL; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY CELL; KIDNEY EPITHELIUM; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCHOOL CHILD; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

EID: 0142187240     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00288.x     Document Type: Article

References (59)

1. CAMERON JS: The enigma of focal segmental glomerulosclerosis. Kidney Int 50(Suppl 57):S119-S131, 1996
2. WHITWORTH JA, TURNER DR, LEIBOWITZ S, CAMERON JS: Focal segmental sclerosis or scarred focal proliferative glomerulonephritis? Clin Nephrol 9:229-235, 1978
3. SCHWARTZ MM, LEWIS EJ: Focal segmental glomerulosclerosis: The cellular lesion. Kidney Int 28:968-974, 1985
4. SCHWARTZ MM, KORBET SM: Primary focal segmental glomerulosclerosis: Pathology, histological variants, and pathogenesis. Am J Kidney Dis 22:874-883, 1993
5. SCHWARTZ MM, EVANS J, BAIN R, KORBET SM: Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesions. J Am Soc Nephrol 10:1900-1907, 1999
6. MEYRIER A: Collapsing glomerulopathy: Expanding interest in a shrinking tuft. Am J Kidney Dis 33:801-803, 1999
7. BARIETY J, BRUNEVAL P, HILL G, et al: Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 12:261-274, 2001
8. KORBET SM, SCHWARTZ MM, LEWIS EJ: Recurrent nephrotic syndrome in renal allografts. Am J Kidney Dis 11:270-276, 1988
9. BARISONI L, KRIZ W, MUNDEL P, D'AGATI V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10:51-61, 1999
10. ROBERTS AB, HEINE VI, FLANDERS KC, SPORN MB: Transforming growth factor-β. Major role in regulation of extracellular matrix. Ann N Y Acad Sci 580:225-232, 1990
11. BORDER WA, NOBLE NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
12. YAMAMOTO T, NOBLE NA, MILLER DE, BORDER WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
13. YAMAMOTO T, NOBLE NA, COHEN AH, et al: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
14. KIM HW, MOON KC, PARK SY, et al: Differential expression of platelet-derived growth factor and transforming growth factor β in relation to progression of IgA nephropathy. Nephrology 7:S131-S139, 2002
15. YOSHIOKA K, TAKEMURA T, MURAKAMI K, et al: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
16. MUNGER JS, HARPEL JG, GLEIZES P-E, et al: Latent transforming growth factor-β: Structural features and mechanisms of activation. Kidney Int 51:1376-1382, 1997
17. BROWN PD, WAKEFIELD LM, LEVINSON AD, et al: Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3:35-43, 1990
18. SHULTZ-CHERRY S, MURPHY-ULLRICH JE: Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923-932, 1993
19. CRAWFORD SE, STELLMACH V, MURPHY-ULLRICH JE, et al: Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93:1159-1170, 1998
20. POCZATEK MH, HUGO C, DARLEY-USMAR V, MURPHY-ULLRICH JE: Glucose stimulation of transforming growth factor-β bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol 157:1353-1363, 2000
21. SHULTZ-CHERRY S, CHEN H, MOSHER DF, et al: Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J Biol Chem 270:7304-7310, 1995
22. MCGREGOR B, COLON S, MUTIN M, et al: Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis. Am J Pathol 144:1281-1287, 1994
23. THOMPSON EM, HUGHES J, VAN NOORDEN S, et al: Expression of the multifunctional extracellular matrix protein thrombospondin in crescentic glomerulonephritis. J Pathol 178:89-94, 1996
24. BLOBE GC, SCHIEMANN WP, LODISH HF: Role of transforming growth factor β in human disease. N Engl J Med 342:1350-1358, 2000
25. WRANA JL, ATTISANO L, WIESER R, et al: Mechanism of activation of the TGF-β receptor. Nature 370:341-347, 1994
26. NAKAO A, IMAMURA T, SOUCHELNYTSKYI S, et al: TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16:5353-5362, 1997
27. MIYAZONO K, TEN DIJKE P, HELDIN C-H: TGF-β signaling by Smad proteins. Adv Immunol 75:115-157, 2000
28. MACIAS-SILVA M, ABDOLLAH S, HOODLESS PA, et al: MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224, 1996
29. ZHANG Y, FENG X-H, WU RY, DERYNCK R: Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168-172, 1996
30. DENNLER S, ITOH S, VIVIEN D, et al: Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promotor of human plasminogen activator inhibitor-type I gene. EMBO J 17: 3091-3100, 1998
31. ZAWEL L, DAI JL, BUCKHAULTS P, et al: Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1: 611-617, 1998
32. MASSAGUE J, WOTTON D: Transcriptional control by TGF-β/Smad signaling. EMBO J 19:1745-1754, 2000
33. YAMAMOTO T, WATANABE T, IKEGAYA N, et al: Expression of types I, II, and III TGF-β receptors in human glomerulonephritis. J Am Soc Nephrol 9:2253-2261, 1998
34. IGLESIAS-DE LA CRUZ MC, ZIYADEH FN, ISONO M, et al: Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62:901-913, 2002
35. HONG SW, ISONO M, CHEN S, et al: Increased glomerular and tubular expression of transforming growth factor-β1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 158:1653-1663, 2001
36. QIAN SQ, KONDAIAH P, ROBERTS AB, SPORN MB: cDNA cloning by PCR of rat transforming growth factor β-1. Nucleic Acid Res 18:3059, 1990
37. WEINSTAT-SASLOW DL, ZABRENETZKY VS, VANHOUTTE K, et al: Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54:6504-6511, 1994
38. BAE HW, GEISER AG, KIM DH, et al: Characterization of the promoter region of the human transforming growth factor-β type II receptor gene. J Biol Chem 270:29460-29468, 1995
39. KIM TS, KIM JY, HONG HK, LEE HS: mRNA expression of glomerular basement membrane proteins and TGF-β1 in human membranous nephropathy. J Pathol 189:425-430, 1999
40. HUGO C, KANG D-H, JOHNSON RJ: Sustained expression of thrombospondin-1 is associated with the development of glomerular and tubulointerstitial fibrosis in the remnant kidney model. Nephron 90:460-470, 2002
41. HUGO C, PICHLER R, MEEK R, et al: Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 48:1846-1856, 1995
42. LYONS R, GENTRY LE, PURCHIO AF, MOSES HL: Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin. J Cell Biol 110:1361-1367, 1990
43. FLAUMENHAFT R, ABE M, MIGNATTI P, et al: Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity. J Cell Biol 118:901-909, 1992
44. TAIPALE J, LOHI J, SAARINEN J, et al: Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 270:4689-4696, 1995
45. BARCELLOS-HOFF MH, DIX TA: Redox-mediated activation of latent transforming growth factor-β1. Mol Endocrinol 10:1077-1083, 1996
46. MUNGER JS, HUANG X, KAWAKATSU H, et al: The integrin αvβ6 binds and activates latent TGF-β1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319-328, 1999
47. BREUSS JM, GILLETT N, LU L, et al: Restricted distribution of integrin β6 mRNA in primate epithelial tissues. J Histochem Cytochem 41:1521-1527, 1993
48. STROSCHEIN SL, WANG W, LUO K: Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor β-induced smad-dependent transcriptional activation. J Biol Chem 274:9431-9441, 1999
49. DATTA PK, BLAKE MC, MOSES HL: Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-β-induced physical and functional interactions between Smads and Sp1. J Biol Chem 275:40014-40019, 2000
50. MASSAGUE J, CHEN YG: Controlling TGF-β signaling. Genes Dev 14:627-644, 2000
51. VERRECCHIA F, MAUVIEL A: Transforming growth factor-beta signaling through the Smad pathway: Role in extracellular matrix gene expression and regulation. J Invest Dermatol 118:211-215, 2002
52. CHEVALIER J, MASURIER C, LAVAUD S, et al: Approach of cellular mechanisms of glomerulosclerosis in a model of accelerated aging the obese Zucker rat. C R Seances Soc Biol Fil 189:987-1007, 1995
53. BARISONI L, KOPP JB: Modulation of podocyte phenotype in collapsing glomerulopathies. Microsc Res Tech 57:254-262, 2002
54. ABBATE M, ZOJA C, MORIGI M, et al: Transforming growth factor-β1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins. A central pathway in progressive glomerulosclerosis. Am J Pathol 161:2179-2193, 2002
55. NAKAMURA T, MILLER D, RUOSLAHTI E, BORDER WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 41:1213-1221, 1992
56. HOLTHÖFER H, SAINO K, MIETTINEN A: Rat glomerular cells do not express podocytic markers when cultured in vitro. Lab Invest 65: 548-557, 1991
57. WEINSTEIN T, CAMERON R, KATZ A, SILVERMAN M: Rat glomerular epithelial cells in culture express characteristics of parietal, not visceral, epithelium. J Am Soc Nephrol 3:1279-1287, 1992
58. ORIKASA M, IWAGANA T, TAKAHASHI-IWANAGA H, et al: Macrophagic cells outgrowth from normal rat glomerular culture: Possible metaplastic change from podocytes. Lab Invest 75:719-733, 1996
59. SALEEM MA, O'HARE MJ, REISER J, et al: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630-638, 2002